Rockefeller Capital Management L.P. lessened its stake in Express Scripts Holding Co (NASDAQ:ESRX) by 10.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 19,964 shares of the company’s stock after selling 2,367 shares during the period. Rockefeller Capital Management L.P.’s holdings in Express Scripts were worth $1,897,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Landaas & Co. WI ADV acquired a new position in Express Scripts in the second quarter worth about $102,000. Kaizen Advisory LLC raised its position in Express Scripts by 147.6% in the second quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock worth $104,000 after purchasing an additional 800 shares in the last quarter. Adviser Investments LLC raised its position in Express Scripts by 321.9% in the second quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after purchasing an additional 1,130 shares in the last quarter. TRUE Private Wealth Advisors acquired a new position in Express Scripts in the third quarter worth about $115,000. Finally, Sun Life Financial INC raised its position in Express Scripts by 758.8% in the second quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after purchasing an additional 1,343 shares in the last quarter. Institutional investors and hedge funds own 84.20% of the company’s stock.
In other news, insider Christine Houston sold 12,898 shares of the stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the sale, the insider now directly owns 110,908 shares of the company’s stock, valued at $9,427,180. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.79% of the stock is owned by corporate insiders.
NASDAQ ESRX opened at $98.19 on Wednesday. Express Scripts Holding Co has a 1-year low of $59.17 and a 1-year high of $98.98. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.77 and a quick ratio of 0.65. The company has a market cap of $54.55 billion, a PE ratio of 13.83, a PEG ratio of 1.22 and a beta of 0.89.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.42 by $0.01. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The business had revenue of $25.56 billion for the quarter, compared to analysts’ expectations of $25.11 billion. During the same period in the prior year, the firm earned $2.51 earnings per share. Express Scripts’s revenue was up 3.6% compared to the same quarter last year. Equities analysts predict that Express Scripts Holding Co will post 9.08 earnings per share for the current year.
Several research analysts recently issued reports on ESRX shares. BidaskClub lowered shares of Express Scripts from a “hold” rating to a “sell” rating in a research report on Saturday, July 21st. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, September 17th. Cowen reissued a “buy” rating and issued a $88.00 price target on shares of Express Scripts in a research report on Friday, November 2nd. Credit Suisse Group lowered shares of Express Scripts from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $90.00 to $96.50 in a research report on Tuesday, September 18th. Finally, Royal Bank of Canada set a $101.00 price objective on shares of Express Scripts and gave the stock a “buy” rating in a report on Thursday, November 1st. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $89.07.
WARNING: This article was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/11/07/rockefeller-capital-management-l-p-trims-position-in-express-scripts-holding-co-esrx.html.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Article: What impact do institutional investors have on markets?
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.